The overwhelming importance of distinctive cardiovascular disease profile in women has stimulated enormous efforts to disclose its cause. In this review, we discuss vascular endothelium as a potential phenotypic marker for the genetic difference. As it is a potentially modifiable factor for cardiovascular disease, every effort should be made to detect it, either directly or indirectly, at the earliest in females who are at risk, so that the future cardiovascular events might be prevented.
Ajayi, A.A. and Halushka, P.V. (2005) Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM98(5): 349-356.
2.
Akishita, M., Kozaki, K., Eto, M.,Yoshizumi, M., Ishikawa, M., Toba, K. et al. (1998) Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun251(1): 17-21.
3.
American Heart Association.Heart Disease and Stroke Statistics: 2004 Update. Available at: http://americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf (accessed January 15, 2004).
4.
Augustin, H.G., Kozian, D.H. and Johnson, R.C. (1994) Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. Bioessays16(12): 901-906.
5.
Bairey Merz, C.N., Shaw, L.J., Reis, S.E., Bittner, V., Kelsey, S.F., Olson, M. et al. (2006) Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease. J Am Coll Cardiol47: S21-S29.
6.
Beckman, J.S. and Koppenol, W.H. (1996) Nitric oxide, Superoxide and Peroxynitrite. The good, the bad, and ugly. Am J physiol271: C1424-C1437.
7.
Bonetti, P.O., Barsness, G.W., Keelan, P.C., Schnell, T.I., Pumper, G.M., Kuvin, J.T. et al. (2003) Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease . J Am Coll Cardiol41(10): 1761-1768.
8.
Bransford, T.L., St Vrain, J.A. and Webb, M. (2001) Abnormal endothelial function in young African-American females: discordance with blood "ow. J Natl Med Assoc93(4): 113-119.
9.
Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F. and Arnal, J.F. (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β . Circulation103(3): 423-428.
10.
Bush, D.E., Jones, C.E., Bass, K.M., Walters, G.K., Bruza, J.M. and Ouyang P. (1998) Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med104(6): 552-558.
11.
Caulin-Glaser, T., Garcia-Cardena, G., Sarrel, P., Sessa, W.C. and Bender, J.R. (1997) 17β-Estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization . Circ Res81(5): 885-892.
12.
Celermajer, D., Sorensen, K., Gooch, V., Spiegelhalter, D.J., Miller, O.I., Sullivan, I.D. et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet340(8828): 1111-1115.
13.
Celermajer, D.S., Sorensen, K., Ryalls, M., Robinson, J., Thomas, O., Leonard, J.V. et al. (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol22(3): 854-858.
14.
Celermajer, D.S., Sorensen, K.E., Spiegelhalter, D.J., Georgakopoulos, D., Robinson, J. and Dean"eld, J.E. (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol24(2): 471-476.
15.
Celermajer, D.S., Sorensen, K.E., Bull, C., Robinson, J. and Dean"eld, J.E. (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol24(6): 1468-1474.
16.
Chaveau, M., Levy, B., Dessanges, J.F., Savin, E., Bailliart, O. and Martineaud, J.P. (1985) Quantitative doppler blood "ow measurement method and in vivo calibration. Cardiovasc Res19(11): 700-706.
17.
Chen, Z.,Yuhanna, I.S., Galcheva-Gargova, Z.I., Karas, R.H., Mendelsohn, M.E. and Shaul, P.W. (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest103(3): 401-406.
18.
Chen, W., Srinivasan, S.R., Li, S., Boerwinkle, E. and Berenson, G.S. (2004) Gender-speci"c in"uence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart Study. Hypertension44(5): 668-673.
19.
Choi, B.G. and McLaughlin, M.A. (2007) Why men's hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am36(2): 365-377.
20.
Cohn, J.N. (2001) Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision makingAm J Hypertens14: 258S-263S.
21.
Cooke, J.P. and Tsao, P.S. (1993) Cytoprotective effects of nitric oxide: Circulation 88(5): 2451-2454.
22.
Cooper, B.C., Gokina, N.I. and Osol, G. (2007) Testosterone replacement increases vasodilatory reserve in androgen-de"cient female rats. Fertil Steril87(2): 422-425.
23.
Dan, P., Cheung, J.C., Scriven, D.R. and Moore, E.D. (2003) Epitope-dependent localization of estrogen receptor-α, but not -β, in en face arterial endotheliumAm J Physiol Heart Circ Physiol284(4): H1295-H1306.
24.
D'Ascenzo, S., Millimaggi, D., Di Massimo, C., Saccani-Jotti, G., Botrè, F., Carta, G. et al. (2007) Detrimental effects of anabolic steroids on human endothelial cells. Toxicol Lett169(2): 129-136.
Dubey, R.K., Gillespie, D.G., Imthurn, B., Rosselli, M., Jackson, E.K. and Keller, P.J. (1999) Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension33(1): 177-182.
27.
Farhat, M.Y., Lavigne, M.C. and Ramwell, P.W. (1996) The vascular protective effects of estrogen. FASEB J10(5): 615-624.
28.
Fishman, A.P. (1982) Endothelium: A distributed organ of diverse capabilities . Ann NY Acad Sci401: 1-8.
29.
Forte, P., Kneale, B.J., Milne, E., Chowienczyk, P.J., Johnston, A., Benjamin, N. et al. (1998) Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension32(4): 730-734.
30.
Geary, G.G., Krause, D.N. and Duckles, S.P. (2000) Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanismsAm J Physiol Heart Circ Physiol279(2): H511-H519.
31.
Geraldes, P., Sirois, M.G., Bernatchez, P.N. and Tanguay, J.F. (2002) Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 Nitrogen-activated protein kinase. Arterioscler Thromb Vasc Biol22(10): 1585-1590.
32.
Gerhard, M., Walsh, B.W., Tawakol, A., Haley, E.A., Creager, S.J., Seely, E.W. et al. (1998) Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation98(12): 1158-1163.
33.
Gilligan, D.M., Quyyumi, A.A. and Cannon R.O., 3rd. (1994) Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation89(6): 2545-2551.
34.
Gilligan, D.M., Badar, D.M., Panza, J.A., Quyyumi, A.A. and Cannon, R.O. 3rd. (1994) Acute vascular effects of estrogen in postmenopausal women. Circulation90(2): 786-791.
35.
Gonzales, R.J., Ghaffari, A.A., Duckles, S.P. and Krause, D.N. (2005) Testosterone treatment increases thromboxane function in rat cerebral arteriesAm J Physiol Heart Circ Physiol289(2): H578-H585.
36.
Grif"ths, K.A., Sader, M.A., Skilton, M.R., Harmer, J.A. and Celermajer, D.S. (2003) Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. J Am Coll Cardiol42(4): 698-704.
37.
Hashimoto, M., Akishita, M., Eto, M., Ishikawa, M., Kozaki, K., Toba, K. et al. (1995) Modulation of endothelium-dependent "ow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation92: 3431-3435.
38.
Hashimoto, M., Akishita, M., Eto, M., Kozaki, K., Ako, J., Sugimoto, N. et al. (1998) The impairment of "ow - mediated vasodilatation in obese men with visceral fat accumulation. International Journal of Obesity22(5): 477-484.
39.
Haynes, M.P., Sinha, D., Russell, K.S., Collinge, M., Fulton, D., Morales-Ruiz, M. et al. (2000) Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res87(8): 677-682.
40.
Herrington, D.M., Braden, G.A., Williams, J.K. and Morgan, T.M. (1994) Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol73(13): 951-952.
41.
Hochman, J.S., Tamis, J.E., Thompson, T.D., Weaver, W.D., White, H.D., Van de Werf, F. et al. (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigatorsN Engl J Med341: 226-232.
42.
Hodges, Y.K., Tung, L.,Yan, X.D., Graham, J.D., Horwitz, K.B. and Horwitz, L.D. (2000) Estrogen receptors and α: prevalence of estrogen receptor β mRNA in human vascular smooth muscle and transcriptional effects . Circulation101(15): 1792-1798.
43.
Iliescu, R., Campos, L.A., Schlegel, W.P., Morano, I., Baltatu, O. and Bader, M. (2003) Androgen receptor independent cardiovascular action of the antiandrogen "utamide. J Mol Med81(1): 420-427.
44.
Jin, H., Lin, J., Fu, L., Mei, YF, Peng, G., Tan, X. et al. (2007) Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells. Biochem Cell Biol85(2): 246-251.
Kahonen, M., Tolvanen, J.P., Sallinen, K., Wu, X., and Porsti, I. (1998) In"uence of gender on control of arterial tone in experimental hypertension. Am J Physiol Heart Circ Physiol275: H15-H22.
47.
Kannel,W.B., Hjortland, M.C., McNamara, P.M. and Gordon, T. (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med85(4): 447-452.
48.
Kauser, K. and Rubanyi, G.M. (1994) Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol Heart Circ267: H2311-H2317.
49.
Kauser, K. and Rubanyi, G.M. (1995) Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension25: 517-523.
50.
Keaney, J.F. Jr., Shwaery, G.T., Xu, A., Nicolosi, R.J., Loscalzo, J., Foxall, T.L. et al. (1994) 17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation89(5): 2251-2259.
51.
Kip, K.E., Marroquin, O.C., Kelley, D.E., Johnson, B.D., Kelsey, S.F., Shaw, L.J. et al. (2004) Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation109: 706-713.
52.
Knot, H.J., Lounsbury, K.M., Brayden, J.E. and Nelson, M.T. (1999) Gender differences in coronary artery diameter re"ect changes in both endothelial Ca2+ and ecNOS activity. Am J Physiol Heart Circ Physiol276: H961-H969.
53.
Koh, K.K., Blum, A., Hathaway, L., Mincemoyer, R., Csako, G., Waclawiw, M.A. et al. (1999) Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation100(18): 1851-1857.
54.
Koh, K.K., Jin, D.K.,Yang, S.H., Lee, S.K., Hwang, H.Y., Kang, M.H. et al. (2001) Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation103(15): 1961-1966.
55.
Koledova, V.V. and Khalil, R.A. (2007) Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert Rev Cardiovasc Ther5(4): 777-789.
56.
Kuikka, J.T., Raitakari, O.T. and Gould, K.L. (2001) Imaging of the endothelial dysfunction in coronary atherosclerosis. Eur J Nucl Med28(10): 1567-1578.
57.
Kuvin, J.T., Patel, A.R., Sliney, K.A., Pandian, N.G., Rand, W.M., Udelson, J.E. et al. (2001) Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol38(7): 1843-1849.
58.
Lieberman, E.H., Gerhard, M.D., Uehata, A., Walsh, S.W., Selwyn, A.P., Ganz, P. et al. (1994) Estrogen improves endothelium-dependent, "ow-mediated vasodilation in postmenopausal women. Ann Intern Med121(12): 936-941.
59.
Liu, M.Y., Hattori,Y., Fukao, M., Sato, A., Sakuma, I. and Kanno, M. (2001) Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term de"ciency of oestrogen and during oestrus cycle. Br J Pharmacol132(5): 1035-1046.
60.
Ludmer, P.L., Selwyn, A.P., Shook, T.L., Wayne, R.R., Mudge, G.H., Alexander, R.W. et al. (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med315(17): 1046-1051.
McCrohon, J.A., Adams, M.R., McCredie, R.J., Robinson, J., Pike, A., Abbey, M. et al. (1996) Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol45(4): 435-441.
63.
McCrohon, J.A., Walters, W.A., Robinson, J.T., McCredie, R.J., Turner, L., Adams, M.R. et al. (1997) Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol29(7): 1432-1436.
64.
McLenachan, J.M., Vita, J., Fish, D.R., Treasure, C.B., Cox, D.A., Ganz, P. et al. (1990) Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation82(4): 1169-1173.
65.
Mendelsohn, M.E. (2002) Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol90(1A): 3F-6F.
66.
Mendelsohn, M.E. and Karas, R.H. (1994) Estrogen and the blood vessel wall. Curr Opinion Cardiol9(5): 619-626.
67.
Michel, T. (1999) Targeting and translocation of endothelial nitric oxide synthase. Braz J Med Biol Res32(11): 1361-1366.
68.
Montalcini, T., Gorgone, G., Gazzaruso, C., Sesti, G., Perticone, F. and Pujia, A. (2007) Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis18(1): 9-13.
69.
Mueller, S.O. and Korach, K.S. (2001) Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr Opin Pharmacol1(6): 613-619.
70.
Mulvihill, N.T., Foley, J.B., Murphy, R.T., Curtin, R., Crean, P.A. and Walsh M. (2001) Risk strati"cation in unstable angina and non -Q wave myocardial infarction using soluble cell adhesion molecules. Heart85(6): 623-627.
71.
Nisolle, M., Gillerot, S., Casanas-Roux, F., Squif"et, J., Berliere, M. and Donnez, J. (1999) Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum Reprod14(11): 2844-2850.
72.
Oliver, J.J. and Webb, D.J. (2003) Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol23(4): 554-566.
73.
Orshal, J.M. and Khalil, R.A. (2004) Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol286: R233-R249.
74.
Ospina, J.A., Duckles, S.P. and Krause, D.N. (2003) 17β-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilationAm J Physiol Heart Circ Physiol285(1): H241-H250.
75.
Patel, A.R., Kuvin, J.T., Sliney, K.A., Rand, W.M., Pandian, N.G. and Karas, R.H. (2005) Peripheral vascular endothelial function correlates with exercise capacity in women. Clin Cardiol28(9): 433-436.
76.
Pepine, C.J., Kerensky, R.A., Lambert, C.R., Smith, K.M., von Mering, G.O., Sopko, G. et al. (2006) Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol47: S30-S35.
77.
Perregaux, D., Chaudhuri, A., Rao, S., Airen, A., Wilson, M., Sung, B.H. et al. (2000) Brachial vascular reactivity in blacks. Hypertension36(5): 866-871.
78.
Polderman, K.H., Stehouwer, C.D., van Kamp, G.J., Dekker, G.A., Verheugt, F.W. and Gooren, L.J. (1993) In"uence of sex hormones on plasma endothelin levelsAnn Intern Med118(6): 429-432.
79.
Reis, S.E., Gloth, S.T., Blumenthal, R.S., Resar, J.R., Zacur, H.A., Gerstenblith, G. et al. (1994) Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation89(1): 52-60.
80.
Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. and Cook N.R. (2002) Comparison of C-Reactive protein and low density lipoprotein cholesterol levels in the prediction of "rst cardiovascular events . N Engl J Med347(20): 1557-1565.
81.
Rodriguez, L.G., Al"eri, A.B. and Cubeddu, L.X. (1997) Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program . J Cardiovasc Risk4: 367-372.
82.
Rubanyi, G.M., Romero, C. and Vanhouette, P.M. (1986) Flow-induced release of endothelium-derived relaxing factor. Am J physiol250: H1145-H1149.
83.
Rubanyi, G.M., Freay, A.D., Kauser, K., Sukovich, D., Burton, G., Lubahn, D.B. et al. (1997) Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest99(10): 2429-2437.
84.
Rubio-Gayosso, I., Garcia-Ramirez, O., Gutierrez-Serdan, R., Guevara-Balcazar, G., Munoz-Garcia, O., Morato-Cartajena, T. et al. (2002) Testosterone inhibits bradykinin-induced intracellular calcium kinetics in rat aortic endothelial cells in culture . Steroids67(5): 393-397.
85.
Russell, K.S., Haynes, M.P., Caulin-Glaser, T., Rosneck, J., Sessa, W.C. and Bender, J. (2000) Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. J Biol Chem275(7): 5026-5030.
86.
Russell, K.S., Haynes, M.P., Sinha, D., Clerisme, E. and Bender, J.R. (2000) Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA97(11): 5930-5935.
87.
Sarabi, M., Millgard, J. and Lind, L. (1999) Effects of age, gender and metabolic factors on endothelium-dependent vasodilation: a population-based study. J Intern Med246(3): 265-274.
88.
Shaw, L.J., Shaw, R.E., Radford M., et al. (2004) for the ACC-National Cardiovascular Data Registry. Sex and ethnic differences in the prevalence of signi"cant and severe coronary artery disease in the ACC-National Cardiovascular Data registryCirculation110: SII1800.
89.
Simoncini, T., Mannella, P., Fornari, L., Varone, G., Caruso, A. and Genazzani, A.R. (2003) Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology144(8): 3449-3455.
90.
Sorensen, K.E., Celermajer, D.S., Georgakopoulos, D., Hatcher, G., Betteridge, D.J. and Dean"eld, J.E. (1994) Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest93(1): 50-55.
91.
Sorensen, K.E., Celermajer, D.S., Spiegalhalter, D.S., Georgakopoulos, D., Robinson, J., Thomas, O. et al. (1995) Non-invasive measurement of endothelium dependent arterial responses in man: accuracy and reproducibility. Br Heart J74(3): 247-253.
92.
Sorensen, K.E., Dorup, I., Hermann, A.P. and Mosekilde, L. (1998) Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function . Circulation97(13): 1234-1238.
93.
Stamler, J.S., Singel, D.J. and Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-activated forms. Science258(5090): 1898-1902.
94.
Stampfer, M.J., Colditz, G.A., Willett, W.C., Manson, J.E., Rosner, B., Speizer, F.E. et al. (1991) Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Eng J Med325(11): 756-762.
95.
Steinberg, H.O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A.D. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest97(11): 2601-2610.
96.
Sumi, D., Hayashi, T., Jayachandran, M. and Iguchi, A. (2001) Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor α through estrogen receptor mediated system. Life Sci69(14): 1651-1660.
97.
Suresh, K. (1999) Vascular endothelium: role in health. Indian Heart J51: 334-335.
98.
Suwaidi, J.A., Hamasaki, S., Higano, S.T., Nishimura, R.A., Holmes, D.R. Jr. and Lerman, A. (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation101(9): 948-954.
99.
Taddei, S., Virdis, A., Ghiadoni, L., Mattei, P., Sudano, I., Bernini, G. et al. (1996) Menopause is associated with Endothelial Dysfunction in Women. Hypertension28(4): 576-582.
100.
Tan, E., Gurjar, M.V., Sharma, R.V. and Bhalla, R.C. (1999) Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration . Cardiovasc Res43(3): 788-797.
101.
Tesfamariam, B. and Ogletree, M.L. (1995) Dissociation of endothelial cell dysfunction and blood pressure in SHR. Am J Physiol269: H189-H194.
102.
Thompson, J. and Khalil, R.A. (2003) Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol30: 1-15.
103.
Thorne, S., Mullen, M.J., Clarkson, P., Donald, A.E. and Dean"eld, J.E. (1998) Early endothelial dysfunction in adults at risk for atherosclerosis. Different response to L-arginine. J Am Coll Cardiol32(1): 110-116.
104.
Ting, H.H., Timimi, F.K., Haley, E.A., Roddy, M.A., Ganz, P. and Creager, M.A. (1997) Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation95(12): 2617-2622.
105.
Topper, J.N., Cai, J., Falb, D. and Gimbrone, M.A. Jr. (1996) Identi"cation of vascular endothelial genes differentially responsive to "uid mechanical stimuli: Cyclooxygenase-3, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA93(19): 10417-10422.
106.
Tsurumi, Y., Nagashima, H., Ichikawa, K., Sumiyoshi, T. and Hosoda, S. (1995) In"uence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol26(5): 1242-1250.
107.
Ueheta, A., Lieberman, E.H., Meredith, I., Anderson, T., Polak, J., Ganz, P. et al. (1992) Non-invasive assessment of "ow-mediated vasodilation in brachial arteries: diminished response in young males compared to femalesCirculation (Supplement I) 86(4): I-620.
108.
Urstad, K.J. and Johansson, J. (2001) Gender difference in age-related changes in vascular function. J Intern Med250(1): 29-36.
109.
Vita, J.A., Treasure, C.B., Nabel, E.G., McLenachan, J.M., Fish, R.D.,Yeung, A.C. et al. (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation81(2): 491-497.
110.
Vogel, R.A. and Corretti, M.C. (1998) Estrogens, progestins, and heart disease: can endothelial function divine the bene"t?Circulation97(13): 1223-1226.
111.
Wagner, A.H., Schroeter, M.R. and Hecker, M. (2001) 17 β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J15: 2121-2130.
112.
Walsh, B.W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V. and Sacks, F.M. (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Eng J Med325(17): 1196-1204.
113.
Wellman, G.C., Bonev, A.D., Nelson, M.T. and Brayden, J.E. (1996) Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca2+-dependent K+ channels. Circ Res79(5): 1024-1030.
114.
Woodman, O.L. (1995) Modulation of vasoconstriction by endothelium-derived nitric oxide: the in"uence of vascular disease. Clin Exp Pharmacol Physiol22(9): 585-593.
115.
Yang, S., Bae, L. and Zhang, L. (2000) Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol36(2): 242-247.
116.
Yang,Y. and Loscalzo, J. (2000) Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation101(8): 2144-2148.
117.
Yildiz, O. and Seyrek, M. (2007) Vasodilating mechanisms of testosterone. Exp Clin Endocrinol Diabetes115(1): 1-6.
